Logos Global Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Logos Global Management's VKTX Position: Q3 2026 in Review
Logos Global Management opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 200,000 shares worth $6.52M. The stake represents 0.35% of the portfolio and ranks #55 among its holdings.
439 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Logos Global Management held 200,000 shares of Viking Therapeutics worth $6.52M as of Q3 2026.
- Viking Therapeutics was a new Logos Global Management position in Q3 2026.
- Viking Therapeutics made up 0.35% of Logos Global Management's portfolio in Q3 2026, its #55 holding.
- 439 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Logos Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.